NCT05953064View on ClinicalTrials.gov

Effects of DHA-NAT on Postprandial Lipidaemia in Healthy Male Subjects

NAActive, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

October 31, 2023

Study Completion Date

April 1, 2025

Conditions
Hypertriglyceridemia
Interventions
OTHER

DHA-NAT

Endogenous metabolite of omega-3 fatty acid docosahexaenoic acid

OTHER

Placebo

Vehicle control (H2O) for the intervention used in the experimental arm (DHA-NAT).

Trial Locations (1)

2900

Center for Clinical Metabolic Research, Herlev-Gentofte Hospital, Hellerup

All Listed Sponsors
lead

University Hospital, Gentofte, Copenhagen

OTHER